Navigation Links
Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
Date:11/24/2008

months following cessation of treatment. Physicians and patients are encouraged to report such cases by calling 1-800-593-2214.

Incidence of Adverse Events

There are no new adverse events specific to PEGINTRON as compared to INTRON A; however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. The most common adverse events associated with PEGINTRON were "flu-like" symptoms, occurring in approximately 50% of patients, which may decrease in severity as treatment continues. Application site disorders were common (47%), but all were mild (44%) or moderate (4%) and no patient discontinued, and included injection site inflammation and reaction (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2% of patients receiving PEGINTRON. Alopecia (thinning of the hair) is also often associated with alpha interferons including PEGINTRON.

Psychiatric adverse events, which include insomnia, were common (57%) with PEGINTRON but similar to INTRON A (58%). Depression was most common at 29%. Suicidal behavior including ideation, suicidal attempts, and completed suicides occurred in 1% of patients during or shortly after completing treatment with PEGINTRON.

The following serious or clinically significant adverse events have been reported at a frequency less than 1% with PEGINTRON or interferon alpha: Severe decreases in neutrophil or platelet counts, hypothyroidism, hyperglycemia, hypotension, arrhythmia, ulcerative and hemorrhagic colitis, development or exacerbation of autoimmune disorders including thyroiditis, RA, systemic lupus erythematosus, psoriasis, pulmonary disorders (dyspnea, pulmonary infiltrates, pneumonitis and pneumonia, some resulting in patient deaths), urticaria, angioedema, bronchoconstriction, anaphylaxis, retinal hemorrhages, and cotton wool spots.

In the PEGINTRON/REBETOL combination tria
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
2. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
3. Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)
4. Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
5. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
6. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
7. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
8. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
9. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
10. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
11. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015 The Judicial Panel ... week about whether to centralize Inferior vena cava (IVC) ... IVC manufacturer, Cook Medical, have already been centralized by ... implanted in patients at risk for a pulmonary embolism. ... traveling to the lungs. Claims against Bard and Cook ...
(Date:7/29/2015)... -- ViaCyte, Inc., a privately-held regenerative medicine company with the first stem ... trials, today announced the opening of a second site in its ... T olerability, and E fficacy of VC-01™ Combination P ... is the first in Canada , will be ... , Alberta.  The lead Edmonton ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/-- LabStyle Innovations Corp. (DRIO), ... in a national broadcast news segment in Australia ... Australia following regulatory and reimbursement approval in that ... the 1.2 million Australians living with diabetes. As a case ... a great solution for a 13 year old boy with ...
Breaking Medicine Technology:IVC filter litigation continues; law firm provides free information to IVC filter patients 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 3
... Technologies (AIT), a company focused on developing critical, ... segments by applying its patented-protected technology platform, announced ... 1,500 square foot analytical facility in the Pittsburgh ... the south side of Pittsburgh at the River ...
... 2011 Animas Corporation and LifeScan, Inc., both ... Diabetes Companies, today announced plans to further build ... market innovative new products and tools for people ... include more closely aligning their commercial organizations to ...
Cached Medicine Technology:Applied Isotope Technologies Opens New Facility in PLSG Life Sciences Campus 2Animas and LifeScan Strengthen Strategic Focus to Better Serve People Living with Diabetes 2Animas and LifeScan Strengthen Strategic Focus to Better Serve People Living with Diabetes 3Animas and LifeScan Strengthen Strategic Focus to Better Serve People Living with Diabetes 4
(Date:7/29/2015)... ... July 29, 2015 , ... Gender minority people who ... Massachusetts law has provided legal protections against discrimination on the basis of gender ... protect against discrimination based on gender identity in places open to the public, ...
(Date:7/29/2015)... ... ... " Core Organizer ” was featured on NewsWatch as part of its monthly AppWatch, ... iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted ... organized. , Wouldn’t it be great if everyone could be a little more organized? ...
(Date:7/29/2015)... ... July 29, 2015 , ... Join Luz Delia Gerber and Abbi Ferrin ... Well-Being begins with understanding how the body actually works. A state of mindfulness allows ... will receive tips on how to forge this new relationship with their bodies. , ...
(Date:7/29/2015)... ... ... Ticket Down is a reliable source of authentic tickets for the international friendly ... international soccer schedule of matches played on American soil continues to grow each year. ... world’s greatest teams, Brazil, will travel to North America to compete with the United ...
(Date:7/29/2015)... MOUNT LAUREL, NJ (PRWEB) , ... July 29, ... ... Manager Certification’s (the Commission) CCM® credential for a five-year period, expiring November 30, ... of its CCM credential by submitting an application demonstrating the program’s compliance with ...
Breaking Medicine News(10 mins):Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:Get More Organized with the Core Organizer App 2Health News:Pampering and Empowerment Abound at Final Event in Luz Delia Gerber’s Book Unveiling 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3
... of the heart may put young people at risk for ... protein // and is noticeable after the growth spurt during ... on exertion, and a family history of sudden death in ... can be seen on an electrocardiogram, but formal diagnosis requires ...
... may be what you need say researchers. In a recent ... vegetables which may reduce the risk of ischemic strokes, ... cut off oxygen supply to the brain. Carotenoids are the ... researchers measured the levels in blood samples of nearly 22,000 ...
... The latest research uncovers more evidence that soy plays ... rich source of isoflavones and also may contain high ... to be beneficial for breast cancer and prostate cancer, ... beneficial for endometrial cancer. Endometrial cancer is cancer affecting ...
... identify which postmenopausal women are at an increased risk ... predictor of bone fracture in postmenopausal women without a ... is measured by a T-score. As the T-score decreases, ... what level of a T-score indicates an increased risk. ...
... heartbeats also known as atrial fibrillation run a higher ... because the irregular beating // causes blood to pool, ... and travels to the brain. A new test to ... standard tests, find researchers. ,Investigators evaluated about 150 ...
... United States each year. On average, men who smoke shorten ... smoke cut their life expectancy by about 15 years . ... 1964, the Surgeon General’s Report showed smoking was linked to ... bronchitis in both men and women. Doctors now say that ...
Cached Medicine News:
... 5 mm suture anchor that incorporates a small ... for maximum pull-out strength in soft bone. The ... possibility of locking the second suture after the ... on the distal part of the insertion shaft ...
The Duet EnCompass Pelvic Floor Diagnostic System is the only equipment specifically designed to perform urodynamics, anorectal manometry, EMG and pudendal nerve latency studies on a single software ...
... answer is simple: to provide better care for ... patients with lower urinary tract symptoms (LUTS) includes ... and, due to increases in reimbursement, it now ... however, you are sending them to someone who ...
... Corkscrew FT II (fully threaded) is a ... to be inserted flush with the cortical ... anchor stability. The full thread design substantially ... with protruding eyelets. Especially advantageous when poor ...
Medicine Products: